Tofersen, a new drug approved by the FDA for a genetic form of ALS, delays symptom progression and death and in about one-quarter of participants leads to stabilization or improvement. “Stopping disease progression and making improvements over 3 to 5 years is unheard of in this type of ALS.”

Published 4 hours ago

Source: reddit.com

Tofersen, a new drug approved by the FDA for a genetic form of ALS, delays symptom progression and death and in about one-quarter of participants leads to stabilization or improvement. “Stopping disease progression and making improvements over 3 to 5 years is unheard of in this type of ALS.”

Tofersen, a new drug approved by the FDA for a genetic form of ALS, delays symptom progression and death and in about one-quarter of participants leads to stabilization or improvement. “Stopping disease progression and making improvements over 3 to 5 years is unheard of in this type of ALS.”

submitted by /u/mvea
[link] [comments]

Categories

science

Read Original Article

Related Articles from reddit.com

Half of suicide victims don't have known psychiatric risk factors, genetic studies reveal less likelihood of depression gene presence, suggesting unique anonymity in risk factors

TikTok says new 'wellness' features can help build healthy habits. Should we be using apps for that? | 'Just another data collection mechanism,' says researcher

Up to 10% price increase in mobile phone prices in January 2026 - Egypt Independent

DOJ Reaffirms Disney’s $10M Payment To Settle Privacy Allegations Over Labelling Of Children’s Videos On YouTube

An Anti-A.I. Movement Is Coming. Which Party Will Lead It?

NYC mayoral inauguration bans Flipper Zero, Raspberry Pi devices